Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

New research suggests that specific biologic medications could be a breakthrough treatment for COPD and asthma. The drugs, which target particular white blood cells to reduce inflammation, may be ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Antibiotic demand for pneumonia and COPD in the top 20 countries showed high global consumption. Researchers conducted a ...

In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...

VIEW THE AGENDA Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

Breathing should be effortless . But for millions, conditions like asthma and COPD (Chronic Obstructive Pulmonary Disease) ...

The study followed 351 patients across four Korean hospitals who had received anti-tuberculosis treatment for more than six months. These individuals were monitored over 11 years (132 months) to ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...